Most Recent
The organiser of the Big Red Bash outback music festival has appealed a judgment denying it coverage for $3.2 million cancellation of the festival during the first wave of the coronavirus pandemic
Avant Insurance has challenged a Federal Court judge’s interpretation of the Insurance Contracts Act in its second attempt to avoid liability for the defence costs of a plastic surgeon named in a class action brought over botched breast augmentations.
Lawyers leading a class action against the Commonwealth Bank over its alleged money laundering compliance failures are getting their ducks in a row in the event the Full Court rules the court has the power to shut out unregistered group members from a class action.
Embattled war veteran Ben Roberts-Smith continues to pursue legal action against his ex-wife, having applied for leave to appeal a Federal Court decision disallowing cross-examination over allegations she accessed his private emails.
A class action waiver in the terms and conditions of tickets purchased by US passengers embarking on the fateful Ruby Princess cruise at the height of the first COVID-19 wave was neither unfair nor onerous, an appeals court has heard.
A case before the High Court could have major implications for company directors, giving shareholders in class actions the power to drag them before court for public examination.
The High Court has bolstered the position of businesses hiring independent contractors with two rulings clarifying the importance of the contract in determing the status of workers.
The Full Federal Court has held Facebook can be sued in Australia for allegedly disclosing the personal data of over 300,000 users to political research firm Cambridge Analytica.
The former CEO of Blue Star Helium is challenging a ruling that slugged him with a $40,000 penalty and a four-year ban for failing to disclose to shareholders the identify of the buyer behind a botched sale of Texas oil assets.
Consumer goods giant Reckitt-Benckiser is seeking special leave from the High Court to challenge a Full Court judgment that overturned a finding that AFT Pharmaceuticals ads' for its painkiller Maxigesic were misleading.